Obsessive-Compulsive Disorder. Mixed obsessional thoughts and acts
Conditions
Interventions
Intervention 1: Intervention group will receive a Echium amoenum-Melissa officinalis syrup, 0.3 milliliter per kilogram of body weight and 50 mg Fluvoxamine tablets daily for 8 weeks. Intervention 2:
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
13 Years to 17 Years
Inclusion criteria
Inclusion criteria: Obsessive-Compulsive Disorder with a diagnosis of pediatric psychiatry according to DSM-5 criteria Ages 13 to 17 years
Exclusion criteria
Exclusion criteria: Psychosis Bipolar disorder Catatonic symptoms Drug abuse Severe or debilitating illnesses Phenobarbital consumption Oxazepam consumption Sedative drugs consumption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Obsessive score on children's Yale-Brown Obsessive Compulsive questionnaire. Timepoint: pretest, 4 weeks after beginning, post-test (at the end of 8 weeks). Method of measurement: children's Yale-Brown Obsessive Compulsive questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score. Timepoint: pretest, post-test (at the end of 8 weeks). Method of measurement: The World Health Organization Quality of Life Questionnaire.;Anxiety score. Timepoint: pretest, 4 weeks after beginning, post-test (at the end of 8 weeks). Method of measurement: Spence Children's Anxiety Questionnaire.;Depression score. Timepoint: pretest, 4 weeks after beginning, post-test (at the end of 8 weeks). Method of measurement: Maria Kovas Depression Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Hosseini Abrishami
Mashhad University of Medical Sciences
Outcome results
None listed